Alvotech Warrant (ALVOW)

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

The chart shows the growth of an initial investment of $10,000 in Alvotech Warrant, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.

Alvotech Warrant (ALVOW) has returned -52.30% so far this year and -79.47% over the past 12 months.

Based on dividend-adjusted daily data since Jun 16, 2022, ALVOW's average daily return is +0.44%, while the average monthly return is +1.99%. At this rate, your investment would double in approximately 2.9 years.

Historically, 46% of months were positive and 54% were negative. The best month was Dec 2022 with a return of +66.1%, while the worst month was Nov 2025 at -53.9%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 6 months.

On a daily basis, ALVOW closed higher 36% of trading days. The best single day was Feb 23, 2026 with a return of +72.2%, while the worst single day was Oct 25, 2022 at -47.6%.

Alvotech Warrant has an annualized alpha of 172.60%, beta of 0.59, and R² of 0.00 versus S&P 500 Index. Calculated based on daily prices since June 17, 2022.

• This stock tended to rise when S&P 500 Index fell (downside capture of -73.10%), but participation in market rallies was also limited (-78.19%) — a profile typical of counter-cyclical assets.
• Beta of 0.59 may look defensive, but with R² of 0.00 this stock is largely uncorrelated with S&P 500 Index — low beta reflects independence, not downside protection. See the Volatility section for a true picture of this stock's risk.
• R² of 0.00 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

ALVOW ranks 24 for risk / return — below 24% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.

The table below present risk-adjusted performance metrics for Alvotech Warrant (ALVOW) and compare them to a chosen benchmark (S&P 500 Index).

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.

The table below displays the maximum drawdowns of the Alvotech Warrant. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Alvotech Warrant was 97.20%, occurring on Feb 20, 2026. The portfolio has not yet recovered.

The current Alvotech Warrant drawdown is 94.66%.

The chart below shows the rolling one-month volatility.

The chart below illustrates the trends in the financial health of Alvotech Warrant over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

The Valuation section provides an overview of how Alvotech Warrant is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.